Girard Partners’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $1.65M | Buy |
8,413
+151
| +2% | +$31.2K | 0.16% | 108 |
|
|
2024
Q1 | $1.78M | Buy |
8,262
+126
| +2% | +$26.5K | 0.17% | 109 |
|
|
2023
Q4 | $1.71M | Sell |
8,136
-358
| -4% | -$76.4K | 0.17% | 112 |
|
|
2023
Q3 | $1.7M | Sell |
8,494
-830
| -9% | -$165K | 0.19% | 108 |
|
|
2023
Q2 | $1.73M | Buy |
9,324
+425
| +5% | +$78.5K | 0.18% | 104 |
|
|
2023
Q1 | $1.7M | Buy |
8,899
+1,132
| +15% | +$205K | 0.19% | 105 |
|
|
2022
Q4 | $1.31M | Buy |
7,767
+858
| +12% | +$149K | 0.15% | 134 |
|
|
2022
Q3 | $1.22M | Buy |
6,909
+815
| +13% | +$161K | 0.16% | 113 |
|
|
2022
Q2 | $1.25M | Buy |
6,094
+474
| +8% | +$100K | 0.16% | 116 |
|
|
2022
Q1 | $1.34M | Buy |
5,620
+694
| +14% | +$163K | 0.15% | 117 |
|
|
2021
Q4 | $1.13M | Buy |
4,926
+171
| +4% | +$37.6K | 0.12% | 124 |
|
|
2021
Q3 | $919K | Buy |
4,755
+1,004
| +27% | +$203K | 0.12% | 127 |
|
|
2021
Q2 | $797K | Buy |
3,751
+43
| +1% | +$9.08K | 0.1% | 132 |
|
|
2021
Q1 | $757K | Buy |
3,708
+374
| +11% | +$73.7K | 0.11% | 128 |
|
|
2020
Q4 | $607K | Sell |
3,334
-1,084
| -25% | -$184K | 0.09% | 137 |
|
|
2020
Q3 | $739K | Sell |
4,418
-241
| -5% | -$40.6K | 0.12% | 123 |
|
|
2020
Q2 | $757K | Sell |
4,659
-404
| -8% | -$72.4K | 0.14% | 120 |
|
|
2020
Q1 | $875K | Buy |
5,063
+330
| +7% | +$65.7K | 0.17% | 108 |
|
|
2019
Q4 | $950K | Buy |
4,733
+1
| +0% | +$205 | 0.16% | 118 |
|
|
2019
Q3 | $1M | Buy |
4,732
+369
| +8% | +$77.1K | 0.19% | 109 |
|
|
2019
Q2 | $847K | Buy |
4,363
+130
| +3% | +$24K | 0.15% | 122 |
|
|
2019
Q1 | $696K | Buy |
4,233
+539
| +15% | +$95.3K | 0.13% | 134 |
|
|
2018
Q4 | $695K | Sell |
3,694
-61
| -2% | -$11.3K | 0.15% | 126 |
|
|
2018
Q3 | $639K | Buy |
3,755
+263
| +8% | +$44.3K | 0.11% | 142 |
|
|
2018
Q2 | $572K | Buy |
3,492
+326
| +10% | +$53.2K | 0.11% | 157 |
|
|
2018
Q1 | $512K | Buy |
3,166
+237
| +8% | +$37.7K | 0.12% | 150 |
|
|
2017
Q4 | $428K | Sell |
2,929
-77
| -3% | -$11K | 0.08% | 184 |
|
|
2017
Q3 | $408K | Buy |
3,006
+159
| +6% | +$20.1K | 0.08% | 174 |
|
|
2017
Q2 | $357K | Buy |
2,847
+613
| +27% | +$73.3K | 0.08% | 186 |
|
|
2017
Q1 | $265K | Buy |
2,234
+50
| +2% | +$6.01K | 0.06% | 199 |
|
|
2016
Q4 | $252K | Sell |
2,184
-110
| -5% | -$12.2K | 0.07% | 189 |
|
|
2016
Q3 | $240K | Buy |
+2,294
| New | +$239K | 0.08% | 176 |
|
Other funds holding CME
Girard Partners's CME Position: Q2 2024 in Review
Girard Partners increased its CME Group (CME) stake by 1.8% in Q2 2024, buying an estimated $31.2K and bringing the position to 8,413 shares worth $1.65M. The position accounts for 0.16% of the portfolio, ranked #108.
Girard Partners first reported a position in CME in Q3 2016 and has held it in 32 quarters since. The position peaked at $1.78M in Q1 2024. 1,377 funds tracked by Wall St. Rank hold CME as of Q2 2024.
- Girard Partners held 8,413 shares of CME Group worth $1.65M as of Q2 2024.
- Girard Partners bought 151 CME Group shares in Q2 2024, an estimated $31.2K.
- CME Group made up 0.16% of Girard Partners's portfolio in Q2 2024, its #108 holding.
- Girard Partners first reported a position in CME Group in Q3 2016 and has held it in 32 quarters since.
- Girard Partners's CME Group position peaked at $1.78M in Q1 2024.
- 1,377 funds tracked by Wall St. Rank held CME Group as of Q2 2024.
Based on Girard Partners's 13F filing for Q2 2024, filed 12 Aug 2024.